ArticleJournal of family medicine and primary care2025
Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population.
Anuradha Nadda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.